Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $361.83 | 21 | 78.4% |
| Education | $99.95 | 1 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $169.22 | 10 | $0 (2021) |
| Janssen Biotech, Inc. | $122.68 | 3 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $40.81 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.55 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.99 | 1 | $0 (2021) |
| Celgene Corporation | $19.98 | 1 | $0 (2021) |
| PFIZER INC. | $19.62 | 1 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $18.00 | 1 | $0 (2021) |
| Masimo Corporation | $16.93 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.93 | 1 | Masimo Corporation ($16.93) |
| 2021 | $444.85 | 21 | AbbVie Inc. ($169.22) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2022 | Masimo Corporation | RAS-45 RRa Adult/Pediatric Acoustic Respiration Sensor (Device), rainbow SET, EMMA | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Devices | ||||||
| 09/28/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/18/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.98 | General |
| Category: Neuroscience | ||||||
| 08/12/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/29/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/25/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Gastroenterology | ||||||
| 05/14/2021 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/19/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Immunology | ||||||
| 04/19/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Immunology | ||||||
| 03/31/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Gastroenterology | ||||||
| 03/26/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Immunology | ||||||
| 03/10/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 03/05/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2021 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/29/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: IMMUNOLOGY | ||||||
| 01/20/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 179 | 249 | $83,290 | $18,745 |
| 2022 | 3 | 139 | 237 | $76,495 | $16,527 |
| 2021 | 4 | 352 | 448 | $74,252 | $26,052 |
| 2020 | 4 | 539 | 749 | $121,640 | $37,114 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 116 | $38,234 | $9,286 | 24.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 37 | $21,800 | $4,316 | 19.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 66 | $15,061 | $3,321 | 22.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,225 | $1,317 | 21.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 15 | $1,970 | $505.65 | 25.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 173 | $55,187 | $11,874 | 21.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 36 | $15,120 | $3,303 | 21.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 28 | $6,188 | $1,350 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 221 | 306 | $42,840 | $16,048 | 37.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 68 | 68 | $14,280 | $4,320 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 58 | $11,948 | $4,113 | 34.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,184 | $1,571 | 30.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 334 | 532 | $74,480 | $22,834 | 30.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 113 | 113 | $23,730 | $6,705 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 87 | $17,922 | $6,020 | 33.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,508 | $1,556 | 28.2% |
About Amanda St. John, APRN, AGPCNP-C
Amanda St. John, APRN, AGPCNP-C is a Registered Nurse healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2019. The National Provider Identifier (NPI) number assigned to this provider is 1447809256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda St. John, APRN, AGPCNP-C has received a total of $461.78 in payments from pharmaceutical and medical device companies, with $16.93 received in 2022. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($361.83).
As a Medicare-enrolled provider, St. John has provided services to 1,209 Medicare beneficiaries, totaling 1,683 services with total Medicare billing of $98,438. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner, Adult Health
- Location Orlando, FL
- Active Since 09/05/2019
- Last Updated 09/19/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1447809256
Products in Payments
- STELARA (Biological) $122.68
- HUMIRA (Biological) $96.27
- LINZESS (Drug) $56.35
- OCALIVA (Drug) $40.81
- XIFAXAN (Drug) $32.55
- MOTEGRITY (Drug) $21.99
- ZEPOSIA (Drug) $19.98
- XELJANZ (Drug) $19.62
- CIMZIA (Drug) $18.00
- RAS-45 RRa Adult/Pediatric Acoustic Respiration Sensor (Device) $16.93
- VIBERZI (Drug) $16.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Orlando
Boni May, Aprn, APRN
Registered Nurse — Payments: $13,671
April Mieswinkel, Fnp, FNP
Registered Nurse — Payments: $4,549
Nicole Bonilla Jimenez, Msn, MSN
Registered Nurse — Payments: $4,194
Mrs. Amanda Crane, Arnp, ARNP
Registered Nurse — Payments: $3,533
Tiffany Graves, Aprn, APRN
Registered Nurse — Payments: $3,329
Kevin Hendrickson, Np, NP
Registered Nurse — Payments: $3,056